Search

Your search keyword '"Dar, Lalit"' showing total 386 results
Start Over Author "Dar, Lalit" Publication Year Range Last 50 years
386 results on '"Dar, Lalit"'

6. Identification of Human Case of Avian Influenza A(H5N1) Infection, India

Author

Potdar, Varsha, Brijwal, Megha, Lodha, Rakesh, Yadav, Pragya, Jadhav, Santosh, Choudhary, Manohar Lal, Choudhary, Aashish, Vipat, Veena, Gupta, Nivedita, Deorari, Ashok Kumar, Dar, Lalit, and Abraham, Priya

Subjects
Avian influenza -- Case studies -- Diagnosis, Communicable diseases in children -- Case studies -- Diagnosis, Pediatric research, Health
Abstract

Avian influenza viruses remain major threats worldwide, responsible for multiple outbreaks among poultry and episodes of transmission to humans. During January 2003-February 3, 2022, there were 862 reported cases of [...]

Published
2022
Full Text
View/download PDF

9. Effectiveness of BBV152/Covaxin and AZD1222/Covishield vaccines against severe COVID-19 and B.1.617.2/Delta variant in India, 2021: a multi-centric hospital-based case-control study

Author

Bhatnagar, Tarun, Chaudhuri, Sirshendu, Ponnaiah, Manickam, Yadav, Pragya D, Sabarinathan, R, Sahay, Rima R, Ahmed, Faheem, Aswathy, S, Bhardwaj, Pankaj, Bilimale, Anil, Kumar, M Santhosh, Logaraj, M., Narlawar, Uday, Palanivel, C, Patel, Prakash, Rai, Sanjay K, Saxena, Vartika, Singh, Arvind, Thangaraj, Jeromie WV, Agarwal, Ashwini, Alvi, Yasir, Amoghashree, Ashok, P, Babu, Dinesh, Bahurupi, Yogesh, Bhalavi, Sangita, Behera, Priyamadhaba, Biswas, Priyanka Pandit, Charan, Jaykaran, Chauhan, Nishant Kumar, Chetak, KB, Dar, Lalit, Das, Ayan, Deepashree, R, Dhar, Minakshi, Dhodapkar, Rahul, Dipu, TS, Dudeja, Mridu, Dudhmal, Manisha, Gadepalli, Ravisekhar, Garg, Mahendra Kumar, Gayathri, AV, Goel, Akhil Dhanesh, Gowdappa, H Basavana, Guleria, Randeep, Gupta, Manoj Kumar, Islam, Farzana, Jain, Mannu, Jain, Vineet, Jawahar, M Lanord Stanley, Joshi, Rajendra, Kant, Shashi, Kar, Sitanshu Sekhar, Kalita, Deepjyoti, Khapre, Meenakshi, Khichar, Satyendra, Kombade, Sarika Prabhakar, Kohli, Sunil, Kumar, Abhinendra, Kumar, Anil, Kumar, Deepak, Kulirankal, Kiran G, Leela, KV, Majumdar, Triparna, Mishra, Baijayantimala, Misra, Puneet, Misra, Sanjeev, Mohapatra, Prasanta Raghab, Murthy, M Narayana, Nyayanit, Dimpal A, Patel, Manish, Pathania, Monika, Patil, Savita, Patro, Binod Kumar, Jalandra, Ramniwas, Rathod, Pragati, Shah, Naimesh, Shete, Anita, Shukla, Deepak, Shwethashree, M, Sinha, Smita, Sumana, MN, Surana, Ashish, Trikha, Anjan, Tejashree, A, Venkateshan, Mahalingam, Vijaykrishnan, G, Wadhava, Sarita, Wig, Naveet, Gupta, Nivedita, Abraham, Priya, and Murhekar, Manoj V

Published
2022
Full Text
View/download PDF

11. Effectiveness of an inactivated virus-based SARS-CoV-2 vaccine, BBV152, in India: a test-negative, case-control study

Author

Desai, Devashish, Khan, Adil Rashid, Soneja, Manish, Mittal, Ankit, Naik, Shivdas, Kodan, Parul, Mandal, Ayan, Maher, Ganesh Tarachand, Kumar, Rohit, Agarwal, Ayush, Gowda, Naveen R, H, Vikas, Kumar, Parmeshwar, Pandey, Shivam, Pandey, R M, Kumar, Arvind, Ray, Animesh, Jorwal, Pankaj, Nischal, Neeraj, Choudhary, Aashish, Brijwal, Megha, Madan, Karan, Lodha, Rakesh, Sinha, Sanjeev, Dar, Lalit, Wig, Naveet, and Guleria, Randeep

Published
2022
Full Text
View/download PDF

13. Fast Viral Diagnostics: FTIR-Based Identification, Strain-Typing, and Structural Characterization of SARS-CoV-2

Author

Lahiri, Pooja, Das, Souvik, Thakur, Shivani, Mehra, Rukmankesh, Ranjan, Piyush, Wig, Naveet, Dar, Lalit, Bhattacharyya, Tarun Kanti, Sengupta, Sanghamitra, and Lahiri, Basudev

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has triggered an ongoing global pandemic, necessitating rapid and accurate diagnostic tools to monitor emerging variants and preparedness for the next outbreak. This study introduces a multidisciplinary approach combining Fourier Transform Infrared (FTIR) microspectroscopy and Machine learning to comprehensively characterize and strain-type SARS-CoV-2 variants. FTIR analysis of pharyngeal swabs from different pandemic waves revealed distinct vibrational profiles, particularly in nucleic acid and protein vibrations. The spectral wavenumber range between 1150 and 1240 cm–1was identified as the classification marker, distinguishing Healthy (noninfected) and infected samples. Machine learning algorithms, with neural networks exhibiting superior performance, successfully classified SARS-CoV-2 variants with a remarkable accuracy of 98.6%. Neural networks were also able to identify and differentiate a small cohort infected with influenza A variants, H1N1 and H3N2, from SARS-CoV-2-infected and Healthy samples. FTIR measurements further show distinct red shifts in vibrational energy and secondary structural alterations in the spike proteins of more transmissible forms of SARS-CoV-2 variants, providing experimental validation of the computational data. This integrated approach presents a promising avenue for rapid and reliable SARS-CoV-2 variant identification, enhancing our understanding of viral evolution and aiding in diagnostic advancements, particularly for an infectious disease with unknown etiology.

Published
2024
Full Text
View/download PDF

14. Virological and cytological changes in tears and conjunctiva of patients with COVID-19

Author

Angmo, Dewang, Mahalingam, Karthikeyan, Kakkar, Aanchal, Rathod, Aishwarya, Meena, Suman, Kaur, Avneet, Choudhary, Aashish, Sharma, Puneet, Dar, Lalit, Samaddar, Arpan, Trikha, Anjan, Saxena, Rohit, Titiyal, Jeewan, and Sharma, Namrata

Subjects
Virulence (Microbiology) -- Analysis, Eye diseases -- Risk factors -- Prevention, Tearing -- Composition, Conjunctiva -- Analysis, Health
Abstract

Byline: Dewang. Angmo, Karthikeyan. Mahalingam, Aanchal. Kakkar, Aishwarya. Rathod, Suman. Meena, Avneet. Kaur, Aashish. Choudhary, Puneet. Sharma, Lalit. Dar, Arpan. Samaddar, Anjan. Trikha, Rohit. Saxena, Jeewan. Titiyal, Namrata. Sharma Purpose: [...]

Published
2023

21. Poor outcomes in patients with cirrhosis and Corona Virus Disease-19

Author

Shalimar, Elhence, Anshuman, Vaishnav, Manas, Kumar, Ramesh, Pathak, Piyush, Soni, Kapil Dev, Aggarwal, Richa, Soneja, Manish, Jorwal, Pankaj, Kumar, Arvind, Khanna, Puneet, Singh, Akhil Kant, Biswas, Ashutosh, Nischal, Neeraj, Dar, Lalit, Choudhary, Aashish, Rangarajan, Krithika, Mohan, Anant, Acharya, Pragyan, Nayak, Baibaswata, Gunjan, Deepak, Saraya, Anoop, Mahapatra, Soumya, Makharia, Govind, Trikha, Anjan, and Garg, Pramod

Published
2020
Full Text
View/download PDF

22. Adverse outcomes in patients hospitalized with pneumonia at age 60 or more: A prospective multi-centric hospital-based study in India.

Author

Kanungo, Suman, Bhattacharjee, Uttaran, Prabhakaran, Aslesh O., Kumar, Rakesh, Rajkumar, Prabu, Bhardwaj, Sumit Dutt, Chakrabarti, Alok Kumar, Kumar C. P., Girish, Potdar, Varsha, Manna, Byomkesh, Amarchand, Ritvik, Choudekar, Avinash, Gopal, Giridara, Sarda, Krishna, Lafond, Kathryn E., Azziz-Baumgartner, Eduardo, Saha, Siddhartha, Dar, Lalit, and Krishnan, Anand

Subjects
RESPIRATORY syncytial virus infections, OLDER people, PROPORTIONAL hazards models, RESPIRATORY syncytial virus, PNEUMONIA, PNEUMOCOCCAL pneumonia
Abstract

Background: Limited data exists regarding risk factors for adverse outcomes in older adults hospitalized with Community-Acquired Pneumonia (CAP) in low- and middle-income countries such as India. This multisite study aimed to assess outcomes and associated risk factors among adults aged ≥60 years hospitalized with pneumonia. Methods: Between December 2018 and March 2020, we enrolled ≥60-year-old adults admitted within 48 hours for CAP treatment across 16 public and private facilities in four sites. Clinical data and nasal/oropharyngeal specimens were collected by trained nurses and tested for influenza, respiratory syncytial virus (RSV), and other respiratory viruses (ORV) using the qPCR. Participants were evaluated regularly until discharge, as well as on the 7th and 30th days post-discharge. Outcomes included ICU admission and in-hospital or 30-day post-discharge mortality. A hierarchical framework for multivariable logistic regression and Cox proportional hazard models identified risk factors (e.g., demographics, clinical features, etiologic agents) associated with critical care or death. Findings: Of 1,090 CAP patients, the median age was 69 years; 38.4% were female. Influenza viruses were detected in 12.3%, RSV in 2.2%, and ORV in 6.3% of participants. Critical care was required for 39.4%, with 9.9% in-hospital mortality and 5% 30-day post-discharge mortality. Only 41% of influenza CAP patients received antiviral treatment. Admission factors independently associated with ICU admission included respiratory rate >30/min, blood urea nitrogen>19mg/dl, altered sensorium, anemia, oxygen saturation <90%, prior cardiovascular diseases, chronic respiratory diseases, and private hospital admission. Diabetes, anemia, low oxygen saturation at admission, ICU admission, and mechanical ventilation were associated with 30-day mortality. Conclusion: High ICU admission and 30-day mortality rates were observed among older adults with pneumonia, with a significant proportion linked to influenza and RSV infections. Comprehensive guidelines for CAP prevention and management in older adults are needed, especially with the co-circulation of SARS-CoV-2. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

23. Cost of acute respiratory illness episode and its determinants among community-dwelling older adults: a four-site cohort study from India

Author

Krishnan, Anand, primary, Shekhawat, Kusum, additional, Ortega-Sanchez, Ismael R, additional, Kanungo, Suman, additional, Rajkumar, Prabu, additional, Bhardwaj, Sumit Dutt, additional, Kumar, Rakesh, additional, Prabhakaran, Aslesh Ottapura, additional, Gopal, Giridara, additional, Chakrabarti, Alok Kumar, additional, Kumar Chethrapilly Purushothaman, Girish, additional, Potdar, Varsha, additional, Manna, Byomkesh, additional, Gharpure, Radhika, additional, Amarchand, Ritvik, additional, Choudekar, Avinash, additional, Lafond, Kathryn E, additional, Dar, Lalit, additional, Bhattacharjee, Uttaran, additional, Azziz-Baumgartner, Eduardo, additional, and Saha, Siddhartha, additional

Published
2023
Full Text
View/download PDF

24. Nasal shedding of vaccine viruses after immunization with a Russian‐backbone live attenuated influenza vaccine in India

Author

Dar, Lalit, primary, Krishnan, Anand, additional, Kumar, Ramesh, additional, Dhakad, Shivram, additional, Choudekar, Avinash, additional, Bagga, Sumedha, additional, Sharma, Amrit, additional, Kumar, Amit, additional, Jethani, Jyoti, additional, Saha, Siddhartha, additional, Amarchand, Ritvik, additional, Kumar, Rakesh, additional, Choudhary, Aashish, additional, Narayan, Venkatesh Vinayak, additional, Gopal, Giridara, additional, Lafond, Kathryn E., additional, and Lindstrom, Stephen, additional

Published
2023
Full Text
View/download PDF

26. Efficacy of live attenuated and inactivated influenza vaccines among children in rural India: A 2-year, randomized, triple-blind, placebo-controlled trial

Author

Krishnan, Anand, Dar, Lalit, Saha, Siddhartha, Narayan, Venkatesh Vinayak, Kumar, Rakesh, Kumar, Ramesh, Amarchand, Ritvik, Dhakad, Shivram, Chokker, Reshmi, Choudekar, Avinash, Gopal, Giridara, Choudhary, Aashish, Potdar, Varsha, Chadha, Mandeep, Lafond, Kathryn E., Lindstrom, Stephen, Widdowson, Marc-Alain, and Jain, Seema

Subjects
Rural children -- Health aspects, Influenza vaccines -- Testing -- Patient outcomes, Influenza -- Prevention, Pediatric research, Biological sciences
Abstract

Background Influenza is a cause of febrile acute respiratory infection (FARI) in India; however, few influenza vaccine trials have been conducted in India. We assessed absolute and relative efficacy of live attenuated influenza vaccine (LAIV) and inactivated influenza vaccine (IIV) among children aged 2 to 10 years in rural India through a randomized, triple-blind, placebo-controlled trial conducted over 2 years. Methods and findings In June 2015, children were randomly allocated to LAIV, IIV, intranasal placebo, or inactivated polio vaccine (IPV) in a 2:2:1:1 ratio. In June 2016, vaccination was repeated per original allocation. Overall, 3,041 children received LAIV (n = 1,015), IIV (n = 1,010), nasal placebo (n = 507), or IPV (n = 509). Mean age of children was 6.5 years with 20% aged 9 to 10 years. Through weekly home visits, nasal and throat swabs were collected from children with FARI and tested for influenza virus by polymerase chain reaction. The primary outcome was laboratory-confirmed influenza-associated FARI; vaccine efficacy (VE) was calculated using modified intention-to-treat (mITT) analysis by Cox proportional hazards model (PH) for each year. In Year 1, VE was 40.0% (95% confidence interval (CI) 25.2 to 51.9) for LAIV and 59.0% (95% CI 47.8 to 67.9) for IIV compared with controls; relative efficacy of LAIV compared with IIV was -46.2% (95% CI -88.9 to -13.1). In Year 2, VE was 51.9% (95% CI 42.0 to 60.1) for LAIV and 49.9% (95% CI 39.2 to 58.7) for IIV; relative efficacy of LAIV compared with IIV was 4.2% (95% CI -19.9 to 23.5). No serious adverse vaccine-attributable events were reported. Study limitations include differing dosage requirements for children between nasal and injectable vaccines (single dose of LAIV versus 2 doses of IIV) in Year 1 and the fact that immunogenicity studies were not conducted. Conclusions In this study, we found that LAIV and IIV vaccines were safe and moderately efficacious against influenza virus infection among Indian children. Trial registration Clinical Trials Registry of India CTRI/2015/06/005902., Author(s): Anand Krishnan 1,*, Lalit Dar 2, Siddhartha Saha 3, Venkatesh Vinayak Narayan 3, Rakesh Kumar 1, Ramesh Kumar 2, Ritvik Amarchand 1, Shivram Dhakad 2, Reshmi Chokker 1, Avinash [...]

Published
2021
Full Text
View/download PDF

29. EP344/#697 Preliminary characterisation of circulating human papillomavirus 16/18/31/35 antibodies for the detection of cervical neoplasia by a rapid point of care test

Author

Bhatla, Neerja, primary, Kumar, Pankaj, additional, Dar, Lalit, additional, Vashist, Shachi, additional, Brenner, Dean, additional, Christen, Jennifer, additional, Hou, Ching-Wen, additional, Herman, Kirk, additional, Sang, Christopher, additional, Eger, Joshua, additional, Rai, Khushboo, additional, Kumari, Rajesh, additional, and Anderson, Karen, additional

Published
2022
Full Text
View/download PDF

30. Multisite surveillance for influenza and other respiratory viruses in India: 2016–2018

Author

Chadha, Mandeep, primary, Prabhakaran, Aslesh Ottapura, additional, Choudhary, Manohar Lal, additional, Biswas, Dipankar, additional, Koul, Parvaiz, additional, Kaveri, K., additional, Dar, Lalit, additional, Mamta, Chawla Sarkar, additional, Jadhav, Santosh, additional, Bhardwaj, Sumit Dutt, additional, Laserson, Kayla, additional, Saha, Siddhartha, additional, and Potdar, Varsha, additional

Published
2022
Full Text
View/download PDF

31. Clinical presentation, viral kinetics, and management of human monkeypox cases from New Delhi, India 2022

Author

Relhan, Vineet, primary, Sahay, Rima R., additional, Shete, Anita M., additional, Yadav, Pragya D., additional, Sahoo, Bijaylaxmi, additional, Patil, Deepak Y., additional, Kumar, Suresh, additional, Premachandran Syamaladevi, Kannan Sabarinath, additional, Dar, Lalit, additional, Mohandas, Sreelekshmy, additional, and Abraham, Priya, additional

Published
2022
Full Text
View/download PDF

34. Zika a Vector Borne Disease Detected in Newer States of India Amidst the COVID-19 Pandemic

Author

Yadav, Pragya D., primary, Kaur, Harmanmeet, additional, Gupta, Nivedita, additional, Sahay, Rima R., additional, Sapkal, Gajanan N., additional, Shete, Anita M., additional, Deshpande, Gururaj R., additional, Mohandas, Sreelekshmy, additional, Majumdar, Triparna, additional, Patil, Savita, additional, Pandit, Priyanka, additional, Kumar, Abhinendra, additional, Nyayanit, Dimpal A., additional, Sreelatha, K. H., additional, Manjusree, S., additional, Sami, Hiba, additional, Khan, Haris Mazoor, additional, Malhotra, Anuradha, additional, Dhingra, Kanwardeep, additional, Gadepalli, Ravisekhar, additional, Sudha Rani, V., additional, Singh, Manoj Kumar, additional, Joshi, Yash, additional, Dudhmal, Manisha, additional, Duggal, Nandini, additional, Chabbra, Mala, additional, Dar, Lalit, additional, Gawande, Pranita, additional, Yemul, Jyoti, additional, Kalele, Kaumudi, additional, Arjun, Rajalakshmi, additional, Nagamani, K., additional, Borkakoty, Biswa, additional, Sahoo, Ganesh, additional, Praharaj, Ira, additional, Dutta, Shanta, additional, Barde, Pradip, additional, Jaryal, S. C., additional, and Rawat, Vinita, additional

Published
2022
Full Text
View/download PDF

36. A Comprehensive Prospective Study to Understand Chikungunya Infection in Delhi Region during 2010-2011

Author

Broor Shobha, Singh Pradeep Kumar, and Dar Lalit

Subjects
medicine.medical_specialty, viruses, virus diseases, Outbreak, General Medicine, medicine.disease, medicine.disease_cause, Arbovirus, Virus, Dengue fever, Internal medicine, medicine, In patient, Chikungunya, Prospective cohort study, Viral load
Abstract

INTRODUCTION: Chikungunya is an arbovirus causing febrile illness with high strike rate and is known for outbreaks in more than 60 countries globally. During 2010-2011 unusual high number of suspected Chikungunya infection patients attended AIIMS OPD, Delhi, India. The NCR region with its semiarid geography restricts arbovirus outbreaks to monsoon months and is previously known for Dengue outbreaks although Chikungunya outbreaks were previously unknown to the region. The surge in suspected Chikungunya infection cases indicates a possible outbreak in the NCR region. This comprehensive prospective and follow-up study was designed to understand the Chikungunya infection among patients attending AIIMS OPD during 2010-11. METHOD: During June 2010 to Dec 2011, 2346 blood samples were collected from outpatients and inpatients attending AIIMS OPD, New Delhi. Samples were grouped in acute and chronic cases. Some patients were also enrolled for year-long follow-up study. Serum samples were tested for CHIKV using PCR and for IgM antibodies to chikungunya virus by IgM-capture ELISA. Real-time PCR was performed targeting the E1 gene for viral load determination in patient sera. RESULT: CHIKV positivity of 35% (746/2112) in acute and 67% (156/234) in chronic suspected cases were found by ELISA. most affected patients belonged to the age group >30-45 yrs. and above in both genders. Acute confirmed cases included 383 (51.3%) females and 363 (48.7%) males and chronic includes 92 (58.9%) females and 64 (41.1%) males. Clinical symptoms include polyarthralgia, fever, and rashes. Maximum positivity was seen in Oct-Nov of both years. During follow-up study, 118 patients enrolled, persisting polyarthralgia and anti-CHIKV IgM was detected up to 2 years while circulating CHIKV was detected by PCR up to 3 months in few patients. CONCLUSION: Chikungunya virus has emerged in Delhi during 2010 and contributed to about 30-40% of fever and arthralgia. CHIKV prevalence is highest in post monsoon month of October. The virus can remain in blood circulation for weeks, while anti-CHIKV IgM can persist for more than a year with complaints of periodic polyarthralgia.

Published
2020
Full Text
View/download PDF

37. Development of a Sensitive and Specific Novel qPCR Assay for Simultaneous Detection and Differentiation of Mucormycosis and Aspergillosis by Melting Curve Analysis

Author

Pandey, Mragnayani, primary, Xess, Immaculata, additional, Sachdev, Janya, additional, Yadav, Usha, additional, Singh, Gagandeep, additional, Pradhan, Dibyabhaba, additional, Xess, Ashit Bhushan, additional, Rana, Bhaskar, additional, Dar, Lalit, additional, Bakhshi, Sameer, additional, Seth, Rachna, additional, Mahapatra, Manoranjan, additional, Jyotsna, Viveka P., additional, Jain, Arun Kumar, additional, Kumar, Rakesh, additional, Agarwal, Reshu, additional, and Mani, Prashant, additional

Published
2022
Full Text
View/download PDF

38. Authors' response

Author

Thakar, Alok, primary, Panda, Smriti, additional, Sakthivel, Pirabu, additional, Brijwal, Megha, additional, Dhakad, Shivram, additional, Choudekar, Avinash, additional, Kanodia, Anupam, additional, Bhatnagar, Sushma, additional, Mohan, Anant, additional, Maulik, SubirK, additional, and Dar, Lalit, additional

Published
2022
Full Text
View/download PDF

40. Evaluation of sensitivity and specificity of high fluorescence lymphocyte count percentage of sysmex XN analyzer in diagnosis of dengue

Author

Brijwal, Megha, primary, Ningombam, Aparna, additional, Acharya, Shreyam, additional, Sarkar, Abhirup, additional, Kumar, Kundan, additional, Routray, Srimantinee, additional, Sachdev, Janya, additional, Srigyan, Deepankar, additional, Choudhary, Aashish, additional, Subramanian, Arulselvi, additional, and Dar, Lalit, additional

Published
2022
Full Text
View/download PDF

41. Clinical presentation, viral kinetics, and management of human monkeypox cases from New Delhi, India 2022.

Author

Relhan, Vineet, Sahay, Rima R., Shete, Anita M., Yadav, Pragya D., Sahoo, Bijaylaxmi, Patil, Deepak Y., Kumar, Suresh, Premachandran Syamaladevi, Kannan Sabarinath, Dar, Lalit, Mohandas, Sreelekshmy, and Abraham, Priya

Subjects
MONKEYPOX, SYMPTOMS, SEXUALLY transmitted diseases, HEPATITIS associated antigen, HEPATITIS B, VIRAL hepatitis
Abstract

We describe the clinical and demographic characteristics, virological follow‐up, and management of five confirmed monkeypox cases from New Delhi, India without any international travel history. The viral load kinetics and viral clearance were estimated in oropharyngeal swabs (OPS), nasopharyngeal swabs (NPS), EDTA blood, serum, urine, and various lesion specimens on every fourth day of follow‐up ranging from 5 to 24 post onset day (POD) of illness. All five cases presented with mild to moderate‐grade intermittent fever, myalgia, and lesions on the genitals, groins, lower limb, trunk, and upper limb. Four cases had non‐tender firm lymphadenopathy. No secondary complications or sexually transmitted infections were recorded in these cases except for the presence of viral hepatitis B infection marker hepatitis B virus surface antigen (HBsAg) in one case. All the cases were mild and had a good recovery. A higher viral load was detected in lesion fluid (POD 9), followed by lesion roof (POD 9), urine (POD 5), lesion base (POD 5), and OPS/NPS (POD 5). The monkeypox virus (MPXV) DNA was detected in clinical samples from 5th to 24th POD. These monkeypox cases without international travel history suggest the underdiagnosed monkeypox infection in the community. This emphasizes the need for active surveillance of MPXV in the high‐risk population such as men having sex with men and female sex workers. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

45. Outcomes of multisystem inflammatory syndrome in children temporally related to COVID-19: a longitudinal study

Author

Bagri, Narendra Kumar, primary, Deepak, Rakesh Kumar, additional, Meena, Suneeta, additional, Gupta, Saurabh Kumar, additional, Prakash, Satya, additional, Setlur, Kritika, additional, Satapathy, Jagatshreya, additional, Chopra, Karan, additional, Upadhyay, Ashish Datt, additional, Ramakrishnan, Sivasubramanian, additional, Lodha, Rakesh, additional, Dar, Lalit, additional, Trikha, Anjan, additional, and Kabra, Sushil Kumar, additional

Published
2021
Full Text
View/download PDF

46. Assessment of Post COVID-19 Health Problems and its Determinants in North India: A descriptive cross section study

Author

Senjam, Suraj Singh, primary, Balhara, Yatan Pal Singh, additional, Kumar, Parmeshwar, additional, Nichal, Neeraj, additional, Manna, Souvik, additional, Madan, Karan, additional, Ahmed, Nishat Hussain, additional, Gupta, Noopur, additional, Sharma, Rajesh, additional, Gupta, Yashdeep, additional, Ray, Animesh, additional, Gupta, Vivek, additional, Vashist, Praveen, additional, Kumar, Atul, additional, Dar, Lalit, additional, Singh Titiyal, Jeevan, additional, Tandon, Radhika, additional, and Gulleira, Randeep, additional

Published
2021
Full Text
View/download PDF

47. Cohort profile: Indian Network of Population-Based Surveillance Platforms for Influenza and Other Respiratory Viruses among the Elderly (INSPIRE)

Author

Krishnan, Anand, primary, Dar, Lalit, additional, Amarchand, Ritvik, additional, Prabhakaran, Aslesh Ottapura, additional, Kumar, Rakesh, additional, Rajkumar, Prabu, additional, Kanungo, Suman, additional, Bhardwaj, Sumit Dutt, additional, Choudekar, Avinash, additional, Potdar, Varsha, additional, Chakrabarti, Alok Kumar, additional, Kumar, CP Girish, additional, Parameswaran, Giridara Gopal, additional, Dhakad, Shivram, additional, Manna, Byomkesh, additional, Choudhary, Ashish, additional, Lafond, Kathryn E, additional, Azziz-Baumgartner, Eduardo, additional, and Saha, Siddhartha, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results